A new player has emerged in China's growing brain-computer interface industry, aiming to tap into the human mind without invasive implants. Gestala, a startup based in Chengdu with offices in Shanghai and Hong Kong, plans to harness ultrasound technology to stimulate and read from the brain.
The company's CEO and co-founder, Phoenix Peng, explains that their device will initially deliver focused ultrasound to treat chronic pain, with pilot studies already showing promising results in reducing pain intensity for up to a week. The first-generation machine will be a stationary benchtop device, requiring patients to visit a clinic for treatment.
Gestala's ultimate goal is to develop a wearable helmet for home use, allowing patients to control their treatment under physician guidance. They aim to expand their offerings beyond chronic pain to include depression, mental illnesses, stroke rehabilitation, Alzheimer's disease, and sleep disorders.
Unlike existing brain-computer interfaces, which rely on electrical signals from neurons, Gestala plans to measure changes in blood flow using ultrasound technology. This approach is seen as more ambitious by Professor Max Riesenhuber of Georgetown University, who notes that extracting information from the brain with ultrasound poses significant engineering challenges, particularly when it comes to interpreting neural activity.
The potential for brain-computer interfaces to revolutionize healthcare and human capabilities has long been a topic of interest. However, most current technologies are still in their infancy, and translating these advancements into practical applications will likely take years.
Gestala's name is inspired by Gestalt psychology, which emphasizes the importance of understanding complex systems as a whole rather than just individual parts. This philosophy underlies the company's ambitious goals for brain-computer interfaces.
The company's CEO and co-founder, Phoenix Peng, explains that their device will initially deliver focused ultrasound to treat chronic pain, with pilot studies already showing promising results in reducing pain intensity for up to a week. The first-generation machine will be a stationary benchtop device, requiring patients to visit a clinic for treatment.
Gestala's ultimate goal is to develop a wearable helmet for home use, allowing patients to control their treatment under physician guidance. They aim to expand their offerings beyond chronic pain to include depression, mental illnesses, stroke rehabilitation, Alzheimer's disease, and sleep disorders.
Unlike existing brain-computer interfaces, which rely on electrical signals from neurons, Gestala plans to measure changes in blood flow using ultrasound technology. This approach is seen as more ambitious by Professor Max Riesenhuber of Georgetown University, who notes that extracting information from the brain with ultrasound poses significant engineering challenges, particularly when it comes to interpreting neural activity.
The potential for brain-computer interfaces to revolutionize healthcare and human capabilities has long been a topic of interest. However, most current technologies are still in their infancy, and translating these advancements into practical applications will likely take years.
Gestala's name is inspired by Gestalt psychology, which emphasizes the importance of understanding complex systems as a whole rather than just individual parts. This philosophy underlies the company's ambitious goals for brain-computer interfaces.